Mitochondrial anti-oxidant protects IEX-1 deficient mice from organ damage during endotoxemia

Int Immunopharmacol. 2014 Dec;23(2):658-63. doi: 10.1016/j.intimp.2014.10.019.

Abstract

Sepsis, a leading cause of mortality in intensive care units worldwide, is often a result of overactive and systemic inflammation following serious infections. We found that mice lacking immediate early responsive gene X-1 (IEX-1) were prone to lipopolysaccharide (LPS) -induced endotoxemia. A nonlethal dose of LPS provoked numerous aberrations in IEX-1 knockout (KO) mice including pancytopenia, increased serum aspartate aminotransferase (AST), and lung neutrophilia, concurrent with liver and kidney damage, followed by death. Given these results, in conjunction with a proven role for IEX-1 in the regulation of reactive oxygen species (ROS) homeostasis during stress, we pre-treated IEX-1 KO mice with Mitoquinone (MitoQ), a mitochondrion-based antioxidant prior to LPS injection. The treatment significantly reduced ROS formation in circulatory cells and protected against pancytopenia and multiple organ failure, drastically increasing the survival rate of IEX-1 KO mice challenged by this low dose of LPS. This study confirms significant contribution of mitochondrial ROS to the etiology of sepsis.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Antioxidants / administration & dosage
  • Antioxidants / therapeutic use*
  • Blood Cell Count
  • Data Interpretation, Statistical
  • Endotoxemia / blood
  • Endotoxemia / chemically induced
  • Endotoxemia / genetics
  • Endotoxemia / prevention & control*
  • Endotoxins / toxicity*
  • Immediate-Early Proteins / deficiency*
  • Immediate-Early Proteins / genetics
  • Kaplan-Meier Estimate
  • Kidney / drug effects
  • Kidney / pathology
  • Liver / drug effects
  • Liver / pathology
  • Lung / drug effects
  • Lung / pathology
  • Membrane Potential, Mitochondrial / drug effects
  • Mice, Knockout
  • Mitochondria / drug effects*
  • Mitochondria / metabolism
  • Organophosphorus Compounds / administration & dosage
  • Organophosphorus Compounds / therapeutic use*
  • Reactive Oxygen Species / metabolism
  • Ubiquinone / administration & dosage
  • Ubiquinone / analogs & derivatives*
  • Ubiquinone / therapeutic use

Substances

  • Antioxidants
  • Endotoxins
  • IEX-1 protein, mouse
  • Immediate-Early Proteins
  • Organophosphorus Compounds
  • Reactive Oxygen Species
  • Ubiquinone
  • mitoquinone
  • endotoxin, Escherichia coli